ING5 and hepatocellular carcinoma: As such, we proved that UA, a natural inhibitor of ING5, has the dual antitumoral functions of inhibiting hepatocellular carcinogenesis and reversing sorafenib resistance of HCC cells, representing a potential therapeutic strategy for HCC treatment.